(Q38690896)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747443%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Opportunistic Neurologic Infections in Patients with Acquired Immunodeficiency Syndrome (AIDS) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747443%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747443%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Paul O'Keefe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747443%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747443%20AND%20SRC:MED&resulttype=core&format=json

Current Neurology and Neuroscience Reports

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747443%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747443%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747443%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747443%20AND%20SRC:MED&resulttype=core&format=json

HIV-associated opportunistic infections of the CNS.

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Toxoplasmic encephalitis in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Neurologic diseases in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Risk factors for Toxoplasma gondii infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Neurotoxoplasmosis diagnosis for HIV-1 patients by real-time PCR of cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Focal neurological disease in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Lymphoma of the central nervous system in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Lymphoma associated with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Primary Central Nervous System Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Progressive multifocal leukoencephalopathy in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

HIV-associated cryptococcal meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

21 January 2018

Cryptococcal meningitis.

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Combination antifungal therapy for cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Cytomegalovirus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Rapid diagnosis of tuberculous meningitis by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Tuberculosis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Tuberculous meningitis in South African urban adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Tuberculous meningitis: a 30-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

21 January 2018

Tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Improving the bacteriological diagnosis of tuberculous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Tuberculous meningitis in adults: review of 48 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

MRI in tuberculous meningoencephalitis: report of four cases and review of the neuroimaging literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-015-0603-8

Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis.

21 January 2018

1 reference

12 December 2020

Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis

1 reference

12 December 2020

Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

1 reference

12 December 2020

Tuberculous meningitis: many questions, too few answers

1 reference

12 December 2020

Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment

1 reference

12 December 2020

Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996.

1 reference

12 December 2020

Primary CNS lymphoma.

1 reference

12 December 2020

AIDS primary central nervous system lymphoma.

1 reference

12 December 2020

Cryptococcal meningitis after unusual exposures to birds

1 reference

12 December 2020

Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT.

1 reference

12 December 2020

Tuberculous meningitis in adults: an eleven-year review.

1 reference

12 December 2020

Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity.

1 reference

12 December 2020

Comparison of commercial kits for detection of cryptococcal antigen

1 reference

12 December 2020

Value of CT scan in the diagnosis of meningitis

1 reference

12 December 2020

Primary central nervous system lymphoma

1 reference

12 December 2020

The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features.

1 reference

12 December 2020

Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994

1 reference

12 December 2020

Tuberculosis trends--United States, 2014.

1 reference

12 December 2020

TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortality

1 reference

12 December 2020

Tuberculous meningitis

1 reference

12 December 2020

Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team

1 reference

12 December 2020